Aetion Raises Another $112M to Empower the Healthcare Indust

Aetion Raises Another $112M to Empower the Healthcare Industry with Data to Make Informed Decisions and Reduce the Time to Market


AlleyWatch
Search
Aetion Raises Another $112M to Empower the Healthcare Industry with Data to Make Informed Decisions and Reduce the Time to Market
While the growth of big data and analytics help businesses understand their customers, serve better ads, and sell more, in healthcare, these same methodologies and technologies have a real enduring, profound societal impact.  Real-world data (RW) and real-world evidence (RWE), made possible by technology, are being used by pharmaceutical companies and the healthcare ecosystem to develop, evaluate, implement, and optimize new treatment approaches.
Aetionis the RWD and RWE platform that enables the healthcare system to harness the power of data to shape the future of medicine. The platform is designed to accelerate the time to market without compromising scientific rigor. For example, the company partnered with the FDA to develop real-world analytics related to COVID and vaccines.

Related Keywords

New York , United States , Carolyn Magill , Warburg Pincus , Jeremy Rassen , Sebastian Schneeweiss , National Cancer Institute , Friends Of Cancer Research , Udall Foundation , Foresite Capital , Flare Capital , Aetion Evidence Platform , Reagan Udall Foundation , Cancer Research , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , கரோலின் ம்யாஜைல் , வார்பர்க் பிங்கஸ் , தேசிய புற்றுநோய் நிறுவனம் , நண்பர்கள் ஆஃப் புற்றுநோய் ஆராய்ச்சி , உடல்ல் அடித்தளம் , விரிவடைய மூலதனம் , ரீகந் உடல்ல் அடித்தளம் , புற்றுநோய் ஆராய்ச்சி ,

© 2025 Vimarsana